Access to anti-retroviral drugs, female in Iceland
Iceland: Access to anti-retroviral drugs, female was 86.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in Iceland, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Iceland stood at 86.0%.
Compared with earlier readings it is up 2.4% on the previous year and up 2.4% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Iceland peaked at 91.0% in 2018 and was at its lowest, 39.0%, in 2000.
That places Iceland 47th out of 141 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in Iceland, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 39.0% | — |
| 2001 | 47.0% | +20.5% |
| 2002 | 54.0% | +14.9% |
| 2003 | 60.0% | +11.1% |
| 2004 | 65.0% | +8.3% |
| 2005 | 67.0% | +3.1% |
| 2006 | 72.0% | +7.5% |
| 2007 | 75.0% | +4.2% |
| 2008 | 76.0% | +1.3% |
| 2009 | 79.0% | +3.9% |
| 2010 | 81.0% | +2.5% |
| 2011 | 82.0% | +1.2% |
| 2012 | 83.0% | +1.2% |
| 2013 | 84.0% | +1.2% |
| 2014 | 84.0% | +0.0% |
| 2015 | 84.0% | +0.0% |
| 2016 | 85.0% | +1.2% |
| 2017 | 78.0% | -8.2% |
| 2018 | 91.0% | +16.7% |
| 2019 | 88.0% | -3.3% |
| 2020 | 84.0% | -4.5% |
| 2021 | 83.0% | -1.2% |
| 2022 | 81.0% | -2.4% |
| 2023 | 84.0% | +3.7% |
| 2024 | 86.0% | +2.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 63.4% | 39.0% | 79.0% | 10 |
| 2010s | 84.0% | 78.0% | 91.0% | 10 |
| 2020s | 83.6% | 81.0% | 86.0% | 5 |
Countries ranked near Iceland
- 44 Uganda 88.0% compare
- 45 Australia 87.0% compare
- 45 Luxembourg 87.0% compare
- 47 Peru 86.0% compare
- 49 Mozambique 85.0% compare
- 50 Côte d'Ivoire 84.0% compare
- 50 Singapore 84.0% compare
- 50 South Africa 84.0% compare
More gender data for Iceland
- Child population (UN estimates and projections) 69.14 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.228 % change on previous year (2030)
- Population 345.21 (2030)
- Working-age population (UN estimates and projections) 345.21 (2030)
- Population (UN estimates and projections), annual growth rate 0.7736 % change on previous year (2030)
- Age population, age 00, female, interpolated 2,155 (2025)
- Age population, age 00, male, interpolated 2,290 (2025)
- Age population, age 01, female, interpolated 2,184 (2025)
- Age population, age 01, male, interpolated 2,324 (2025)
- Age population, age 02, female, interpolated 2,211 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Iceland?
- Access to anti-retroviral drugs, female in Iceland was 86.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Iceland?
- The highest recorded value was 91.0% in 2018.
- What is the lowest access to anti-retroviral drugs, female recorded in Iceland?
- The lowest recorded value was 39.0% in 2000.
- How does Iceland rank for access to anti-retroviral drugs, female?
- Iceland ranks 47th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Iceland?
- Over the last ten years it is up 2.4%. The long-run trend across the full record is rising.
- Where does this Iceland data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.